Details for New Drug Application (NDA): 207968
✉ Email this page to a colleague
The generic ingredient in JADENU SPRINKLE is deferasirox. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the deferasirox profile page.
Summary for 207968
Tradename: | JADENU SPRINKLE |
Applicant: | Novartis |
Ingredient: | deferasirox |
Patents: | 0 |
Suppliers and Packaging for NDA: 207968
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968 | NDA | Novartis Pharmaceuticals Corporation | 0078-0713 | 0078-0713-15 | 30 PACKET in 1 CARTON (0078-0713-15) / 1 GRANULE in 1 PACKET (0078-0713-19) |
JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968 | NDA | Novartis Pharmaceuticals Corporation | 0078-0720 | 0078-0720-15 | 30 PACKET in 1 CARTON (0078-0720-15) / 1 GRANULE in 1 PACKET (0078-0720-19) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 90MG | ||||
Approval Date: | May 18, 2017 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 180MG | ||||
Approval Date: | May 18, 2017 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | 360MG | ||||
Approval Date: | May 18, 2017 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 207968
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968-001 | May 18, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968-003 | May 18, 2017 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | JADENU SPRINKLE | deferasirox | GRANULE;ORAL | 207968-002 | May 18, 2017 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription